Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele

Journal of the American Geriatrics Society

Volumn 46, Issue 8, 1998, Pages 962-967

  Van Der Cammen, T J M ^a   Verschoor, C J ^a   Van Loon, C P M ^a   Van Harskamp, F ^a   De Koning, I ^a   Schudel, W J ^a   Slooter, A J C ^a   Van Broeckhoven, C ^b   Van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR;

EID: 0031859720     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb02749.x     Document Type: Article

References (21)

1. Myers RH, Schaefer EJ, Wilson PWF et al. Apolipoprotein E∈4 association with dementia in a population-based study: The Framingham Study. Neurology 1996;46:673-677.
2. Kuusisto J, Koivisto K, Kervinen K et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population-based study. Br Med J 1994;309:636-638.
3. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vase Biol 1996;16:1250-1255.
4. Kosunen O, Talasniemi S, Lehtovirta M et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-748.
5. Premkumar DRD, Cohen DL, Hedera P et al. Apolipoprotein E-∈4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-2095.
6. Hofman A, Ott A, Breteler MMB et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-154.
7. Rubenstein LZ, Josephson KR, Wieland GD et al. Effectiveness of a geriatric evaluation unit: A randomized clinical trial. N Engl J Med 1984;311:1664-1670.
8. Epstein AM, Hall JA, Besdine R et al. The emergence of geriatric assessment units: The new technology of geriatrics. Ann Intern Med 1987;106:299-303.
9. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
10. Rooymans HGM. The psychiatrist in the general hospital: A review of consultative and liaison psychiatry. Utrecht, The Netherlands: Bohn, Scheltema & Holkema, 1984, p 191. Thesis.
11. Van der Cammen TJM, van Harskamp F, Stronks DL et al. Value of the Mini-Mental State Examination and informants' data for the detection of dementia in geriatric outpatients. Psychol Rep 1992;71:1003-1009.
12. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed revised. Washington DC: American Psychiatric Association, 1987.
13. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 1984;34:939-944.
14. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
15. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:9:1136-1139.
16. Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
17. International Classification of Diseases (9th rev). Clinical Modification 1978. [Dutch edition 1986, Utrecht: de Boer-Cuperus].
18. Wenham PR, Price WH, Blundell G. Apolipoprotein genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
19. Van Duijn CM, de Knijff P, Wehnert A et al. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
20. Bell MA, Ball MJ. Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 1990;11:359-370.
21. Katzel LI, Fleg JL, Paidi M et al. ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. Arterioscler Thromb 1993;13:1495-1500.